Cargando…
Interleukin-1β promotes atheroprotective changes of advanced atherosclerotic lesions in mice
Despite decades of research, our understanding of the processes controlling late-stage atherosclerotic plaque stability remains poor. Although a prevailing hypothesis is that reducing inflammation may improve advanced plaque stability, direct evidence of this is lacking. Therefore, we performed inte...
Autores principales: | Gomez, Delphine, Baylis, Richard A., Durgin, Brittany G., Newman, Alexandra A. C., Alencar, Gabriel F., Mahan, Sidney, St. Hilaire, Cynthia, Muller, Werner, Waisman, Ari, Francis, Sheila E., Pinteaux, Emmanuel, Randolph, Gwendalyn J., Gram, Hermann, Owens, Gary K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130822/ https://www.ncbi.nlm.nih.gov/pubmed/30038218 http://dx.doi.org/10.1038/s41591-018-0124-5 |
Ejemplares similares
-
KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in
Atherosclerotic Plaque Pathogenesis
por: Shankman, Laura S., et al.
Publicado: (2015) -
Activation of the ESC pluripotency factor OCT4 in smooth muscle cells is atheroprotective
por: Cherepanova, Olga A., et al.
Publicado: (2016) -
Cell-specific conditional deletion of interleukin-1 (IL-1) ligands and its receptors: a new toolbox to study the role of IL-1 in health and disease
por: Pinteaux, Emmanuel, et al.
Publicado: (2020) -
Functionality of C-Reactive Protein for Atheroprotection
por: Singh, Sanjay K., et al.
Publicado: (2019) -
Anti-inflammatory and atheroprotective properties of glucagon
por: Osaka, Naoya, et al.
Publicado: (2020)